CSL Behring’s newly expanded facility has been granted approval by the FDA and will begin operations. The expansion significantly increases plasma processing and albumin production capacity at the Kankakee, IL facility. The new facility will use the same technology as CSL Behring’s manufacturing center of excellence in Bern, Switzerland, an important step towards a common fractionation process throughout the company’s global manufacturing network.    The expansion aims to meet growing worl...